(9) Share-Based Compensation
Stock option activity for the nine months ended September 30, 2011 is as follows:
|
|
Number of
Shares
|
|
Weighted Average
Exercise
Price Per Share
|
|
Options outstanding at December 31, 2010
|
|
859
|
|
$
|
9.20
|
|
Granted
|
|
630
|
|
10.84
|
|
Expired
|
|
(76
|
)
|
9.67
|
|
Exercised
|
|
(34
|
)
|
10.99
|
|
Options outstanding at September 30, 2011
|
|
1,379
|
|
9.88
|
|
|
|
|
|
|
|
|
During the nine-month period ended September 30, 2011, the Company issued options to purchase 630 shares of common stock under the 2009 Incentive Plan to the Companys executive officers, other employees and to new members of its Board of Directors, of which 505 will not vest until certain earnings metrics have been achieved. These options were issued with a weighted-average exercise price of $10.84 per share, and a weighted-average grant date fair value of $5.13 per share. All of the options issued have an option termination date of ten years from the option grant date.
The fair value of each option grant was estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions for the nine-month period ended September 30, 2011:
|
|
2011
|
|
Expected life (in years)
|
|
3.0 to 4.0
|
|
Risk-free interest rate
|
|
0.7 to 1.2
|
|
Expected volatility
|
|
49.0 to 67.7
|
|
Dividend yield
|
|
0.0
|
|
Expected option lives and volatilities are based on historical data of the Company. The risk-free interest rate is calculated as the average U.S. Treasury obligation rate that corresponds with the option life.
The Companys outstanding stock options include both non-qualified stock options, which vest over differing periods ranging from the date of issuance up to 36 months from the option grant date, and performance-based stock options, which vest upon achieving operating income margins of six, eight and ten percent as reported in four of five consecutive quarters over the term of the options.
Share-based compensation expense from non-qualified stock options for the three-month periods ended September 30, 2011 and 2010 was approximately $166 and $107, respectively; the related tax benefit was approximately $66 and $42, respectively. Share-based compensation expense from non-qualified stock options for the nine-month periods ended September 30, 2011 and 2010 was approximately $390 and $325, respectively; the related tax benefit was approximately $156 and $127, respectively. As of September 30, 2011 and December 31, 2010, the unrecognized share-based compensation expense related to the grants described above was $879 and $451, respectively.
The Company recorded shared-based compensation expense of $607 and a related tax benefit of approximately $240 for the three months ended September 30, 2011 for the six and eight percent operating margin performance-based stock options. The Company recorded shared-based compensation expense of $1,527 and a related tax benefit of approximately $603 for the nine months ended September 30, 2011 for the performance-based stock options that will vest upon achieving six and eight percent operating income margins as reported in four of five consecutive quarters. No share-based compensation costs for performance-based stock options were recorded for the same periods in 2010. As of September 30, 2011, the unrecognized share-based compensation expense related to these options was approximately $862. In the event that the Company achieves a ten percent operating income margin as reported in four of five consecutive quarters, the Company will recognize up to $1,200 of additional share-based compensation expense.
At September 30, 2011, the aggregate intrinsic value of outstanding non-qualified and performance-based stock options to purchase 1,379 shares of common stock, exercisable non-qualified and performance-based stock options to purchase 334 shares of common stock and non-qualified and performance-based stock options to purchase 772 shares of common stock that are expected to vest was $5,987, $1,753 and $3,545, respectively. At December 31, 2010, the aggregate intrinsic value of outstanding options to purchase 859 shares of common stock was $855.
|